TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)

INTRODUCTION: Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal disease that affects up to 30% of patients with psoriasis. Current challenges in clinical care and research include personalised treatment, understanding the divergence of therapy response and unravelling the multifa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleinrensink, Nienke J, Perton, Frank T, Pouw, Juliëtte N, Vincken, Nanette L A, Hartgring, Sarita A Y, Jansen, Mylène P, Arbabi, Saeed, Foppen, Wouter, de Jong, Pim A, Tekstra, Janneke, Leijten, Emmerik F A, Spierings, Julia, Lafeber, Floris P J G, Welsing, Paco M J, Heijstek, Marloes W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557317/
https://www.ncbi.nlm.nih.gov/pubmed/36216430
http://dx.doi.org/10.1136/bmjopen-2022-064338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557317/
https://www.ncbi.nlm.nih.gov/pubmed/36216430
http://dx.doi.org/10.1136/bmjopen-2022-064338

Ejemplares similares